Concepedia
Author
Nadine Houédé
Also Known As
Christian Funck-Brentano, N Houédé, N. Houede, N. Houedé, N. Houéde, N. Houédé, NADINE HOUEDE, NADINE HOUÉDÉ, Nadine HOUEDE, Nadine Houede
249
Publications
6.9K
Citations
36
H-Index
72
Concepts
All Affiliations
1
26
40
3.6K
2
4
1.7K
3
80
59
5
34
×
All Concepts
69
5.7K
33
Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
Eugene D. Kwon, Charles G. Drake, H. I. Scher, +23
The Lancet Oncology
UrologyOncologyDocetaxel ChemotherapyClinical TrialsImmune Checkpoint Inhibitor +7
2014
1.5K
Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer
Pierre Soubeyran, Marianne Fonck, C. Blanc-Bisson, +15
Journal of Clinical Oncology
2012
424
Erdafitinib or Chemotherapy in Advanced or Metastatic Urothelial Carcinoma
Yohann Loriot, Nobuaki Matsubara, Se Hoon Park, +15
New England Journal of Medicine
2023
255
Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1
Matthew R. Smith, Johann S. de Bono, Cora N. Sternberg, +23
2016
244
Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial
Karim Fizazi, Laura Faivre, F. Lesaunier, +27
UrologyGetug 12Genitourinary CancerMedicineAndrogen Deprivation Therapy +6
2015
236
Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy
Stéphanie Hoppe, M. Rainfray, Marianne Fonck, +17
2013
230
Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old
Éva Compérat, S. Larré, Morgan Rouprêt, +15
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
Urological ResearchUrologyUrothelial Bladder CancerGenitourinary CancerMedicine +5
218
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors
Karim Fizazi, Charles G. Drake, Tomasz M. Beer, +22
European Urology
UrologyHealth SciencesMedicineClinical TrialsPharmacotherapy +6
2020
163
Efficacy and safety of erdafitinib in patients with locally advanced or metastatic urothelial carcinoma: long-term follow-up of a phase 2 study
Arlene O. Siefker‐Radtke, Andrea Necchi, Se Hoon Park, +100
UrologyOncologyMetastatic Urothelial CarcinomaGenitourinary CancerCancer Management +5
2022
162
Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study
Ronan Flippot, Cécile Dalban, Brigitte Laguerre, +23
2019
157
Page 1